Entera Bio Ltd. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 USD | -2.60% | -3.02% | +275.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+275.00% | 80.59M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.03% | 21.96B | |
-8.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- ENTX Stock
- News Entera Bio Ltd.
- Entera Bio Ltd. Auditor Raises 'Going Concern' Doubt